Organon Presents Data on VTAMA Cream’s Impact on Sleep at AAAAI 2026 Annual Meeting How can we address the significant sleep disturbances that affect children with atopic dermatitis and their families? Organon a global healthcare company dedicated to delivering impactful…
Patent Expands Niagen’s Leadership in NAD+ Delivery, Supporting Faster and Safer Treatments Why is the race for intellectual property in the NAD+ market heating up? Niagen Bioscience, Inc. a global leader in NAD+ science and healthy aging, has announced the…
Strategic Collaboration to Convene Global Investors and Leaders for Healthcare Advancement Why is the Middle East emerging as a critical hub for healthcare innovation? NYU Abu Dhabi and RTW Investments, LP, are joining forces to address this question and more.…
Kivu Bioscience Secures HREC Approval and CTN Clearance for Next-Generation ADC Why are next-generation antibody-drug conjugates (ADCs) crucial for advancing cancer treatments? Kivu Bioscience, a clinical-stage biotechnology company based in San Mateo, CA, is making significant strides in this area.…
Leadership Transition Signals Ascensia’s Commitment to Long-Term Growth and Innovation Why is the leadership transition at Ascensia Diabetes Care significant for the global healthcare industry? Ascensia Diabetes Care, a global leader in diabetes management solutions, has announced the appointment of…
Biotech Leader OmniAb, Inc. to Showcase Cutting-Edge Antibody Discovery Technology In the rapidly evolving landscape of biotechnology, where innovation and precision are paramount, OmniAb, Inc. stands out as a leader in discovery research technology. The company, known for its advanced…
Biotech Leader Takes Helm as Synthekine Advances Phase 2 Cancer Study In the rapidly evolving landscape of biotechnology, where precision and innovation are paramount, Synthekine Inc. is making a strategic move to solidify its position. The company, which specializes in…
Rocket Pharmaceuticals to Present at Major Healthcare Conferences in Boston and Miami In the rapidly evolving landscape of genetic therapies, where precision and innovation are paramount, Rocket Pharmaceuticals, Inc. is making significant strides. The company, a fully integrated, late-stage biotechnology…
Seaport Therapeutics Presents New Meta-Analysis Examining the Impact of Clinical Trial Design Factors on Placebo Response in Generalized Anxiety Disorder Trials Seaport Therapeutics a clinical-stage therapeutics company advancing novel neuropsychiatric medicines with a proven strategy and team, today announced the…
bit.bio Accelerates Global Access to Human Cells with New Pricing Model and Distribution Hub Following a record Q4 in sales volume and the successful closing of $50 million in new funding, bit.bio is leveraging its economies of scale to substantially…
GenSight Biologics Bolsters Regulatory Leadership in US and Europe with Two Senior Appointments GenSight Biologics a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, today announced the strategic expansion…
ImmunityBio Reports Productive Regulatory Engagement with Saudi Food and Drug Authority at USA-Saudi Biotech Alliance Meeting Hosted by the Ministry of Investment of Saudi Arabia ImmunityBio, Inc. a commercial stage immunotherapy company developing next generation therapies that drive immunological memory…